124 related articles for article (PubMed ID: 26201319)
1. Novel modulators of hepatosteatosis, inflammation and fibrogenesis.
Lakshman MR; Reyes-Gordillo K; Varatharajalu R; Arellanes-Robledo J; Leckey LC; Garige M; Shah R
Hepatol Int; 2014 Sep; 8 Suppl 2():413-20. PubMed ID: 26201319
[TBL] [Abstract][Full Text] [Related]
2. Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat.
Varatharajalu R; Garige M; Leckey LC; Arellanes-Robledo J; Reyes-Gordillo K; Shah R; Lakshman MR
Am J Pathol; 2014 Jul; 184(7):2035-44. PubMed ID: 24814604
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of thymosin β4 on carbon tetrachloride-induced acute hepatotoxicity in rats.
Reyes-Gordillo K; Shah R; Arellanes-Robledo J; Rojkind M; Lakshman MR
Ann N Y Acad Sci; 2012 Oct; 1269():61-8. PubMed ID: 23045971
[TBL] [Abstract][Full Text] [Related]
4. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
[TBL] [Abstract][Full Text] [Related]
5. Low-
Reyes-Gordillo K; Shah R; Varatharajalu R; Garige M; Leckey LC; Lakshman MR
Oxid Med Cell Longev; 2016; 2016():1840513. PubMed ID: 28074114
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
7. Thymosin
Shah R; Reyes-Gordillo K; Cheng Y; Varatharajalu R; Ibrahim J; Lakshman MR
Oxid Med Cell Longev; 2018; 2018():9630175. PubMed ID: 30116499
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
9. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
Nan YM; Han F; Kong LB; Zhao SX; Wang RQ; Wu WJ; Yu J
Scand J Gastroenterol; 2011 Mar; 46(3):358-69. PubMed ID: 20969493
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stellate cells express thymosin Beta 4 in chronically damaged liver.
Kim J; Wang S; Hyun J; Choi SS; Cha H; Ock M; Jung Y
PLoS One; 2015; 10(3):e0122758. PubMed ID: 25826335
[TBL] [Abstract][Full Text] [Related]
12. Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro.
Zhai X; Qiao H; Guan W; Li Z; Cheng Y; Jia X; Zhou Y
Eur J Pharmacol; 2015 Jan; 746():56-62. PubMed ID: 25445048
[TBL] [Abstract][Full Text] [Related]
13. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
[TBL] [Abstract][Full Text] [Related]
14. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol attenuates the progression of alcohol fatty liver disease in rats.
Liu J; Takase I; Hakucho A; Okamura N; Fujimiya T
Alcohol Clin Exp Res; 2012 Sep; 36(9):1587-99. PubMed ID: 22413959
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.
Da Silva Morais A; Abarca-Quinones J; Horsmans Y; Stärkel P; Leclercq IA
Int J Mol Med; 2007 Jan; 19(1):105-12. PubMed ID: 17143554
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor CD36 mediates inhibition of cholesterol synthesis via activation of the PPARγ/PGC-1α pathway and Insig1/2 expression in hepatocytes.
Rodrigue-Way A; Caron V; Bilodeau S; Keil S; Hassan M; Lévy E; Mitchell GA; Tremblay A
FASEB J; 2014 Apr; 28(4):1910-23. PubMed ID: 24371122
[TBL] [Abstract][Full Text] [Related]
18. Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor γ.
Jiang Y; Wang S; Zhao Y; Lin C; Zhong F; Jin L; He F; Wang H
FASEB J; 2015 May; 29(5):1830-41. PubMed ID: 25609425
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanism of Betaine on Hepatic Lipid Metabolism: Inhibition of Forkhead Box O1 (FoxO1) Binding to Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
Kim DH; Lee B; Kim MJ; Park MH; An HJ; Lee EK; Chung KW; Park JW; Yu BP; Choi JS; Chung HY
J Agric Food Chem; 2016 Sep; 64(36):6819-25. PubMed ID: 27546313
[TBL] [Abstract][Full Text] [Related]
20. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.
Yang L; Chan CC; Kwon OS; Liu S; McGhee J; Stimpson SA; Chen LZ; Harrington WW; Symonds WT; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G902-11. PubMed ID: 16798724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
